XLON
ITX
Market cap23mUSD
Jul 04, Last price
126.50GBP
1D
0.00%
1Q
12.44%
Jan 2017
544.72%
IPO
23.41%
Name
Itaconix PLC
Chart & Performance
P/E
—
P/S
296.00
EPS
—
Div Yield, %
—
Shrs. gr., 5y
-39.41%
Rev. gr., 5y
49.36%
Revenues
8m
+40.46%
Net income
-2m
L-37.64%
CFO
-2m
L+778.08%
Profile
Itaconix plc, together with its subsidiaries, designs, develops, manufactures, and sells bio-based polymers for personal care, home care, and industrial sectors in North America and Europe. The company's home care and industrial products include Itaconix TSI 322, Itaconix DSP 2K, Itaconix TSI 122, and Itaconix VELASOFT water soluble polymers; and Itaconix ZINADOR 22L and 35L, which are water soluble odor neutralizers. Its personal care products comprise Itaconix VELAFRESH ZP20 and ZP30 that are water soluble fixating complexes; and Nouryon Amaze SP, a hair styling ingredient. The company was formerly known as Revolymer plc and changed its name to Itaconix plc in February 2017. Itaconix plc was incorporated in 2012 and is headquartered in Stratham, New Hampshire.
IPO date
Jul 10, 2012
Employees
13
Domiciled in
GB
Incorporated in
GB
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
| Income | |||||||||
Revenues | 7,866 40.46% | 5,600 115.72% | |||||||
Cost of revenue | 9,495 | 7,974 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | (1,629) | (2,374) | |||||||
NOPBT Margin | |||||||||
Operating Taxes | 27 | 8 | |||||||
Tax Rate | |||||||||
NOPAT | (1,656) | (2,382) | |||||||
Net income | (1,536) -37.64% | (2,463) 441.32% | |||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | 12,683 | 387 | |||||||
BB yield | -82.86% | -0.04% | |||||||
| Debt | |||||||||
Debt current | 279 | 180 | |||||||
Long-term debt | 4,193 | 418 | |||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | 632 | 1,000 | |||||||
| Cash flow | |||||||||
Cash from operating activities | (1,923) | (219) | |||||||
CAPEX | (255) | (59) | |||||||
Cash from investing activities | (7,570) | (59) | |||||||
Cash from financing activities | 11,463 | 192 | |||||||
FCF | (5,568) | (375) | |||||||
| Balance | |||||||||
Cash | 8,750 | 597 | |||||||
Long term investments | (4,910) | ||||||||
Excess cash | 3,447 | 317 | |||||||
Stockholders' equity | (79,439) | (54,221) | |||||||
Invested Capital | 92,899 | 53,745 | |||||||
ROIC | |||||||||
ROCE | 498.76% | ||||||||
| EV | |||||||||
Common stock shares outstanding | 12,863 | 448,313 | |||||||
Price | 1.19 -42.62% | 2.07 -33.60% | |||||||
Market cap | 15,307 -98.35% | 929,801 -32.19% | |||||||
EV | 15,939 | 929,802 | |||||||
EBITDA | (1,233) | (2,012) | |||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||